It may never come to fruition, but still nice to see the money flowing towards cure research
"Cantargia is developing a new therapy aimed at removing leukemic stem cells in CML patients and resulting in a permanent cure. The company has now secured financing up to the pre-clinical phase, strengthened the Board, and recruited a CEO."
"Cantargia is developing a new therapy for hematologic malignancies (leukemia). The conceptually new approach has been validated ex vivo with patient-derived leukemic stem cells. The project is based on the original discovery that certain leukemic cells in patients with chronic myeloid leukemia (CML) express a cell-surface receptor, the Interleukin-1 receptor accessory protein (IL1RAP), whereas corresponding normal hematopoietic stem cells do not express this receptor. Cantargia uses this receptor as the target for development of a novel antibody-based therapy for CML."
http://pharmalive.co...0&categoryid=54
